Tonix Pharmaceuticals Holding Corp. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

SALE OF COMMON STOCK (Details Textual)

SALE OF COMMON STOCK (Details Textual) (USD $)	12 Months Ended
SALE OF COMMON STOCK (Details Textual) (USD $)	Dec. 31, 2014	Dec. 31, 2013	Aug. 31, 2013	Jan. 31, 2013
Securities Financing Transaction [Line Items]
Payments of Stock Issuance Costs		$ 1,352us-gaap_PaymentsOfStockIssuanceCosts
Proceeds from Issuance of Common Stock	47,836,000	10,042,000
Class of Warrant or Right, Exercise Price of Warrants or Rights		$ 4.25	$ 4.25	$ 12.00
Description Of Unit		Each Unit consisted of (i) one share of common stock and (ii) one Series A Warrant (the Warrants) to purchase one share of common stock.
Description Of Option Granted Under Underwriting Agreement		the Company also granted the Underwriters an option for a period of 45 days to purchase up to (i) 402,000 additional Units or (ii) 402,000 additional shares of common stock and/or additional Warrants to purchase up to 402,000 shares of common stock, on the same terms, to cover over-allotments, if any.
January 2014 Financing [Member]
Securities Financing Transaction [Line Items]
Stock Issued During Period, Shares, New Issues	2,898,550
Share Price	$ 15.00
Underwriters over allotment number of shares	434,782
Common Stock Issuance, Discount Amount	2,608,695
Common Stock Issuance, Discount Price Per Share	$ 0
Payments of Stock Issuance Costs	215,756
Proceeds from Issuance of Common Stock	40,653,799
July 2014 Financing [Member]
Securities Financing Transaction [Line Items]
Stock Issued During Period, Shares, New Issues	657,000
Share Price	$ 11.90
Payments of Stock Issuance Costs	600,000
Proceeds from Issuance of Common Stock	7,182,670
August 2013 Financing [Member]
Securities Financing Transaction [Line Items]
Underwriters Exercised Overallotment Option To Purchase Additional Warrants		402,000
Class of Warrant or Right, Exercise Price of Warrants or Rights		$ 4.25
Warrants Granted Under Underwriting Agreement		107,200
Discount [Member]
Securities Financing Transaction [Line Items]
Stock Issued During Period Shares Warrants Exercised1		911,200
Class of Warrant or Right, Exercise Price of Warrants or Rights		$ 0.34
Common Stock [Member]
Securities Financing Transaction [Line Items]
Stock Issued During Period Shares Warrants Exercised1		2,680,000
Placement Agents [Member] \| January 2014 Financing [Member]
Securities Financing Transaction [Line Items]
Percentage Of Gross Proceeds Placement Agent Fee	6.00%
Underwriters Warrants [Member] \| August 2013 Financing [Member]
Securities Financing Transaction [Line Items]
Proceeds from Issuance of Common Stock		10,038,013
Underwriters Exercised Overallotment Option To Purchase Additional Warrants		4,020
Class of Warrant or Right, Exercise Price of Warrants or Rights		$ 4.25
Expense Related to Distribution or Servicing and Underwriting Fees		$ 440,787